Hartell, A. (2006). Risk and benefit assessment for Tolcapone in the treatment of Parkinson's disease. Masters thesis, Aston University.
Abstract
DUE TO COPYRIGHT RESTRICTIONS ONLY AVAILABLE FOR CONSULTATION AT ASTON UNIVERSITY LIBRARY AND INFORMATION SERVICES WITH PRIOR ARRANGEMENT
Divisions: | College of Health & Life Sciences > School of Biosciences |
---|---|
Additional Information: | Department of Pharmacy and Biological Sciences. NO SCANNING ALLOWED |
Institution: | Aston University |
Uncontrolled Keywords: | Risk and benifit,Tolcapone,Parkinson's disease |
Last Modified: | 30 Sep 2024 08:18 |
Date Deposited: | 19 Mar 2014 17:40 |
Completed Date: | 2006 |
Authors: |
Hartell, A.
|